TTRX Turn Therapeutics Inc.
$12.69▼ -5.16%
Healthcare
Other
After hours
$11.82▼ -6.86%
Sep 11, 7:30 PM ET
Volume 135.6K
Avg Volume (10D) 116.8K
Key Metrics & Fundamentals
Market Cap
$385.37M
P/E Ratio
–
Div Yield
–%
52W Range
2.57 - 26.50
% vs 50 MA
31.38%
% vs 200 MA
130.10%
RSI-14
66.2
MACD Histogram
+0.3400
Beta (1Y vs SPY)
1.44
Free Cash Flow
-$929,162
Gross Rev
$0
Gross Profit
$0
EBITDA
$1.73M
COGS
–
Operating Exp
$1.63M
Operating Income
-$1.63M
EBIT
-$1.63M
Pretax Income
-$5.85M
Net Income
-$5.85M
EPS (Diluted)
-0.20
Price & Volume History
Loading chart…
Recent News
Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
Business Wire · Sep 10, 2026 12:00 PM
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer
Business Wire · Sep 9, 2026 12:00 PM
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
GlobeNewswire · Sep 8, 2026 11:00 AM
Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch
Business Wire · Aug 20, 2026 12:00 PM
Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results
Business Wire · Aug 12, 2026 8:30 PM
Turn Therapeutics to Ring the Nasdaq Closing Bell on Monday, August 10, 2026
Business Wire · Jul 28, 2026 12:01 PM
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
MarketBeat · Jul 11, 2026 5:02 PM
Turn Therapeutics’ stock jumps on AD data and trial expansion
Clinical Trials Arena · Jul 8, 2026 11:17 AM
Turn Therapeutics Completes Interim Phase 2 Review; Expands GX-03 Study in Atopic Dermatitis
MT Newswires · Jul 7, 2026 12:56 PM
Turn Therapeutics Announces Final Stage 2 Design and Data-Driven Expansion of GX-03 Phase 2 Program in Atopic Dermatitis
Business Wire · Jul 7, 2026 12:05 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See TTRX's money flow as a full page
Social Sentiment
No Reddit posts found for TTRX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.